PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Saalbach, A.* ; Anderegg, U.* ; Wendt, R.* ; Beige, J.* ; Bachmann, A.* ; Klöting, N. ; Blüher, M. ; Zhang, M.Z.* ; Harris, R.C.* ; Stumvoll, M.* ; Tönjes, A.* ; Ebert, T.*

Antifibrotic soluble thy-1 correlates with renal dysfunction in chronic kidney disease.

Int. J. Mol. Sci. 24:13 (2023)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Kidney fibrosis is a major culprit in the development and progression of chronic kidney disease (CKD), ultimately leading to the irreversible loss of organ function. Thymocyte differentiation antigen-1 (Thy-1) controls many core functions of fibroblasts relevant to fibrogenesis but is also found in a soluble form (sThy-1) in serum and urine. We investigated the association of sThy-1 with clinical parameters in patients with CKD receiving hemodialysis treatment compared to individuals with a preserved renal function. Furthermore, Thy-1 tissue expression was detected in a mouse model of diabetic CKD (eNOS-/-; db/db) and non-diabetic control mice (eNOS-/-). Serum and urinary sThy-1 concentrations significantly increased with deteriorating renal function, independent of the presence of diabetes. Serum creatinine is the major, independent, and inverse predictor of serum sThy-1 levels. Moreover, sThy-1 is not only predicted by markers of renal function but is also itself an independent and strong predictor of markers of renal function, i.e., serum creatinine. Mice with severe diabetic CKD show increased Thy-1 mRNA and protein expression in the kidney compared to control animals, as well as elevated urinary sThy-1 levels. Pro-fibrotic mediators, such as interleukin (IL)-4, IL-13, IL-6 and transforming growth factor β, increase Thy-1 gene expression and release of sThy-1 from fibroblasts. Our data underline the role of Thy-1 in the control of kidney fibrosis in CKD and raise the opportunity that Thy-1 may function as a renal antifibrotic factor.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
5.600
0.000
1
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Chronic Kidney Disease ; Fibrosis ; Renal Dysfunction ; Thy-1; Fibroblast Apoptosis; General-population; Up-regulation; All-cause; Lung; Expression; Differentiation; Mortality; Integrin; Roles
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 1661-6596
e-ISSN 1422-0067
Zeitschrift International Journal of Molecular Sciences
Quellenangaben Band: 24, Heft: 3, Seiten: , Artikelnummer: 13 Supplement: ,
Verlag MDPI
Verlagsort Basel
Begutachtungsstatus Peer reviewed
Institut(e) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-506500-001
G-506501-001
Förderungen EFSD Mentorship Programme - AstraZeneca
Swedish Kidney Foundation (Njurfonden)
Stiftelsen Stig och Gunborg Westman
Karolinska Institutet Research Foundation grant
Novo Nordisk postdoctoral fellowship
DGF
DOI 10.3390/ijms24031896
WOS ID 000929675600001
Scopus ID 85147893418
PubMed ID 36768219
Erfassungsdatum 2023-02-19
[➜Korrektur melden]